Ankylosing spondylitis and bowel disease

Wright, 1978, Seronegative polyarthritis: a unified concept, Arthritis and Rheumatism, 21, 619, 10.1002/art.1780210603 Dougados, 1991, The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy, Arthritis and Rheumatism, 34, 1218, 10.1002/art.1780341003 Amor, 1990, Criteria of the classification of spondylarthropathies, Revue du Rhumatisme et des Maladies Osteo-Articulaires, 57, 85 Sieper, 2002, Ankylosing spondylitis: an overview, Annals of the Rheumatic Diseases, 61, iii1, 10.1136/ard.61.suppl_3.iii1 De Keyser, 1998, Bowel inflammation and the spondyloarthropathies, Rheumatic Diseases Clinics of North America, 24, 785, 10.1016/S0889-857X(05)70042-9 Leirisalo-Repo, 1998, Prognosis, course of disease, and treatment of the spondyloarthropathies, Rheumatic Diseases Clinics of North America, 24, 737, 10.1016/S0889-857X(05)70039-9 Moller, 1982, The distribution of clinical findings in Bechterew's syndrome (ankylosing spondylitis) suggests distinct genetic subgroups, Clinical Genetics, 22, 151, 10.1111/j.1399-0004.1982.tb01428.x Purrmann, 1988, HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27, B44, The Journal of Rheumatology, 15, 1658 de Vlam, 2000, Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association, The Journal of Rheumatology, 27, 2860 Brophy, 2001, Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors, The Journal of Rheumatology, 28, 2667 Leirisalo-Repo, 1994, High frequency of silent inflammatory bowel disease in spondylarthropathy, Arthritis and Rheumatism, 37, 23, 10.1002/art.1780370105 Mielants, 1988, Ileocolonoscopic findings in seronegative spondylarthropathies, British Journal of Rheumatology, 27, S95, 10.1093/rheumatology/XXVII.suppl_2.95 Mielants, 1995, The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects, The Journal of Rheumatology, 22, 2266 Mielants, 1995, The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects, The Journal of Rheumatology, 22, 2273 Mielants, 1995, The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint, The Journal of Rheumatology, 22, 2279 Smale, 2001, Inflammatory bowel disease and spondylarthropathy, Arthritis and Rheumatism, 44, 2728, 10.1002/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8 Martinez-Gonzalez, 1994, Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives, British Journal of Rheumatology, 33, 644, 10.1093/rheumatology/33.7.644 Vaile, 1999, Bowel permeability and CD45RO expression on circulating CD20+B cells in patients with ankylosing spondylitis and their relatives, The Journal of Rheumatology, 26, 128 Orchard, 1998, Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history, Gut, 42, 387, 10.1136/gut.42.3.387 van der Linden, 1984, Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria, Arthritis and Rheumatism, 27, 361, 10.1002/art.1780270401 Palm, 2002, Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study), The Journal of Rheumatology, 29, 511 Peeters, 2004, Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease, Annals of the Rheumatic Diseases, 63, 1131, 10.1136/ard.2004.021774 Podswiadek, 2004, The prevalence of radiographic sacroiliitis in patients affected by inflammatory bowel disease with inflammatory low back pain, Reumatismo, 56, 110 Steer, 2003, Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease, The Journal of Rheumatology, 30, 518 Queiro, 2000, Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study, Clinical Rheumatology, 19, 445, 10.1007/s100670070003 Colbert, 2004, The immunobiology of HLA-B27: variations on a theme, Current Molecular Medicine, 4, 21, 10.2174/1566524043479293 Brown, 1997, Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment, Arthritis and Rheumatism, 40, 1823, 10.1002/art.1780401015 Sims, 2004, Genetic susceptibility to ankylosing spondylitis, Current Molecular Medicine, 4, 13, 10.2174/1566524043479284 Enlow, 1980, The spondylitis of inflammatory bowel disease. Evidence for a non-HLA linked axial arthropathy, Arthritis and Rheumatism, 23, 1359, 10.1002/art.1780231205 Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, 411, 599, 10.1038/35079107 Crane, 2002, Role of NOD2 variants in spondylarthritis, Arthritis and Rheumatism, 46, 1629, 10.1002/art.10329 Miceli-Richard, 2002, CARD15/NOD2 analyses in spondylarthropathy, Arthritis and Rheumatism, 46, 1405, 10.1002/art.10196 D'Amato, 2002, The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis, The Journal of Rheumatology, 29, 2470 van der Paardt, 2003, CARD15 gene mutations are not associated with ankylosing spondylitis, Genes and Immunity, 4, 77, 10.1038/sj.gene.6363914 Ferreiros-Vidal, 2003, Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease, The Journal of Rheumatology, 30, 102 Laukens, 2005, CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease, Annals of the Rheumatic Diseases, 64, 930, 10.1136/ard.2004.028837 Bjarnason, 2003, Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis, Gastroenterology, 125, 1598, 10.1053/j.gastro.2003.08.035 Mielants, 1993, Gut inflammation in children with late onset pauci-articular juvenile chronic arthritis and evolution to adult spondyloarthropathy: a prospective study, The Journal of Rheumatology, 20, 1567 Schatteman, 1995, Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study, The Journal of Rheumatology, 22, 680 Cuvelier, 1987, Histopathology of intestinal inflammation related to reactive arthritis, Gut, 28, 394, 10.1136/gut.28.4.394 Demetter, 2002, Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis, The Journal of Pathology, 198, 517, 10.1002/path.1235 De Vos, 1996, Long-term evolution of gut inflammation in patients with spondyloarthropathy, Gastroenterology, 110, 1696, 10.1053/gast.1996.v110.pm8964393 Demetter, 2000, Focal upregulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated lineage, American Journal of Clinical Pathology, 114, 364, 10.1093/ajcp/114.3.364 Demetter, 2000, Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex, Annals of the Rheumatic Diseases, 59, 211, 10.1136/ard.59.3.211 Elewaut, 1998, Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis, Scandinavian Journal of Gastroenterology, 33, 743, 10.1080/00365529850171693 Elewaut, 1998, Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis, The Journal of Rheumatology, 25, 1932 Van Damme, 2001, Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin, Clinical and Experimental Rheumatology, 19, 681 Van Damme, 2001, The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome, Clinical and Experimental Immunology, 125, 383, 10.1046/j.1365-2249.2001.01638.x Van Damme, 2001, Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy, Annals of the Rheumatic Diseases, 60, 495, 10.1136/ard.60.5.495 Demetter, 2005, Colon mucosa of both spondyloarthritis and Crohn's disease patients is enriched with macrophages expressing the scavenger receptor CD163, Annals of the Rheumatic Diseases, 64, 321, 10.1136/ard.2003.018382 Ogura, 2001, frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, 411, 603, 10.1038/35079114 Hoffman, 2003, Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy, Annals of the Rheumatic Diseases, 62, 455, 10.1136/ard.62.5.455 Torok, 2004, Inflammatory bowel disease-specific autoantibodies in HLA-associated spondyloarthropathies: increased prevalence of AS pANCA, Digestion, 70, 49, 10.1159/000080081 Vander Cruyssen, 2005, CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients, Clinical and Experimental Immunology, 140, 354, 10.1111/j.1365-2249.2005.02759.x Severijnen, 1988, Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal flora of patients with Crohn's disease, Digestion, 39, 118, 10.1159/000199614 Severijnen, 1989, Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats, The Journal of Rheumatology, 16, 1061 Mansson, 1971, Arthritis in pigs induced by dietary factor: microbiological, clinical and histological studies, Clinical and Experimental Immunology, 9, 677 Hammer, 1990, Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human b2m: an animal model of HLA-B27-associated human disorders, Cell, 63, 109, 10.1016/0092-8674(90)90512-D Taurog, 1994, The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats, The Journal of Experimental Medicine, 180, 2359, 10.1084/jem.180.6.2359 Breban, 1996, T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats, Journal of Immunology, 156, 794, 10.4049/jimmunol.156.2.794 May, 2003, CD8 alpha beta T cells are not essential to the pathogenesis of arthritis and colitis in HLA-B27 transgenic rats, Journal of Immunology, 170, 1099, 10.4049/jimmunol.170.2.1099 Tran, 2004, HLA-B27 in transgenic rats form disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP, Journal of Immunology, 172, 5110, 10.4049/jimmunol.172.8.5110 Cuvelier, 1992, Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondyloarthropathy, Clinical and Experimental Immunology, 90, 275, 10.1111/j.1365-2249.1992.tb07942.x Baeten, 2000, Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity, Annals of the Rheumatic Diseases, 59, 945, 10.1136/ard.59.12.945 Laloux, 2001, Immunohistological study of the entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis, Annals of the Rheumatic Diseases, 60, 316, 10.1136/ard.60.4.316 Mertz, 2000, Multispecific CD4+T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles, Journal of Immunology, 164, 1529, 10.4049/jimmunol.164.3.1529 Kuon, 2001, Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated disease, Journal of Immunology, 167, 4738, 10.4049/jimmunol.167.8.4738 Thiel, 2000, Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry, Arthritis and Rheumatism, 43, 2834, 10.1002/1529-0131(200012)43:12<2834::AID-ANR25>3.0.CO;2-7 Goodall, 2001, Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4+T cells from humans infected with Chlamydia trachomatis, Clinical and Experimental Immunology, 126, 488, 10.1046/j.1365-2249.2001.01709.x Duchmann, 2001, CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins, Clinical and Experimental Immunology, 123, 315, 10.1046/j.1365-2249.2001.01440.x Salmi, 2001, Human leucocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules, Journal of Immunology, 166, 4650, 10.4049/jimmunol.166.7.4650 Baeten, 2001, Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot study, Arthritis and Rheumatism, 44, 186, 10.1002/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B Yin, 1997, Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis, Arthritis and Rheumatism, 40, 1788, 10.1002/art.1780401010 Rudwaleit, 2001, Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism, Annals of the Rheumatic Diseases, 60, 36, 10.1136/ard.60.1.36 Baeten, 2001, Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha, Annals of the Rheumatic Diseases, 60, 750, 10.1136/ard.60.8.750 Yin, 1999, The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta, Rheumatology, 38, 1058, 10.1093/rheumatology/38.11.1058 Canete, 2000, Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies, Annals of the Rheumatic Diseases, 59, 263, 10.1136/ard.59.4.263 Braun, 1999, Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis, Arthritis and Rheumatism, 42, 2039, 10.1002/1529-0131(199910)42:10<2039::AID-ANR3>3.0.CO;2-6 Baeten, 2002, Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy, The Journal of Pathology, 196, 343, 10.1002/path.1044 Baeten, 2005, Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy, Arthritis Research & Therapy, 7, R359, 10.1186/ar1501 Baeten, 2004, Association of CD163 positive macrophages and local production of CD163 with decreased lymphocyte activation in spondyloarthropathy synovitis, Arthritis and Rheumatism, 50, 1611, 10.1002/art.20174 Cario, 2000, Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease, Infection and Immunity, 68, 7010, 10.1128/IAI.68.12.7010-7017.2000 De Rycke, 2005, Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy, Arthritis and Rheumatism, 52, 2146, 10.1002/art.21155 Braun, 1995, Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis, Arthritis and Rheumatism, 38, 499, 10.1002/art.1780380407 Danning, 2000, Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis, Arthritis and Rheumatism, 43, 1244, 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2 Fiocchi, 1998, Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology, 115, 182, 10.1016/S0016-5085(98)70381-6 Zochling, 2006, ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, 65, 442, 10.1136/ard.2005.041137 Rampton, 1981, Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs, Postgraduate Medical Journal, 57, 297, 10.1136/pgmj.57.667.297 Felder, 2000, Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study, The American Journal of Gastroenterology, 95, 1949, 10.1111/j.1572-0241.2000.02262.x Kaufmann, 1987, Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease, Annals of Internal Medicine, 107, 513, 10.7326/0003-4819-107-4-513 Cipolla, 2002, Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives, Pharmacological Research, 46, 1, 10.1016/S1043-6618(02)00033-6 Evans, 1997, Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease, Gut, 40, 619, 10.1136/gut.40.5.619 Bonner, 2000, Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease, The American Journal of Gastroenterology, 95, 1946, 10.1111/j.1572-0241.2000.02263.x Bonner, 2004, A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease, Inflammatory Bowel Diseases, 10, 751, 10.1097/00054725-200411000-00009 Dougados, 2002, Conventional treatments for ankylosing spondylitis, Annals of the Rheumatic Diseases, 61, iii40, 10.1136/ard.61.suppl_3.iii40 Haibel, 2005, Six months open label trial of leflunomide in active ankylosing spondylitis, Annals of the Rheumatic Diseases, 64, 124, 10.1136/ard.2003.019174 Haibel, 2005, Open label trial of anakinra in active ankylosing spondylitis over 24 weeks, Annals of the Rheumatic Diseases, 64, 296, 10.1136/ard.2004.023176 Van Den Bosch, 2002, Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy, Arthritis and Rheumatism, 46, 755, 10.1002/art.511 Braun, 2002, Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial, Lancet, 359, 1187, 10.1016/S0140-6736(02)08215-6 Gorman, 2002, Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha, The New England Journal of Medicine, 346, 1349, 10.1056/NEJMoa012664 Brandt, 2005, Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis, Rheumatology (Oxford, England), 44, 342, 10.1093/rheumatology/keh475 Braun, 2004, Biological therapies in the spondyloarthritides—the current state, Rheumatology (Oxford, England), 43, 1072, 10.1093/rheumatology/keh205 van der Heijde, 2005, Ankylosing spondylitis study for the evaluation of recombinant infliximab therapy study group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT), Arthritis and Rheumatism, 52, 582, 10.1002/art.20852 Rudwaleit, 2005, Infliximab for the treatment of ankylosing spondylitis, Expert Opinion on Biological Therapy, 5, 1095, 10.1517/14712598.5.8.1095 Haibel H, Rudwaleit M, Brandt HC, et al. Adalimumab reduces spinal symptoms in active ankylosing spondylitis—clinical and MRI results of a 52-week open-label trial. Arthritis and Rheumatism; 2006; 54: 678–681. van der Heijde, 2005, Adalimumab therapy results in significant reductions of signs and symptoms in subjects with ankylosing spondylitis: the ATLAS trial, Arthritis and Rheumatism, 52, S281 Braun, 2006, First update of the International ASAS Consensus Statement for the use of anti-TNF agents in patients with ankylosing spondylitis, Annals of the Rheumatic Diseases, 65, 316, 10.1136/ard.2005.040758 Van den Bosch, 2000, Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms, Lancet, 356, 1821, 10.1016/S0140-6736(00)03239-6 Generini, 2004, Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations, Annals of the Rheumatic Diseases, 63, 1664, 10.1136/ard.2003.012450 Marzo-Ortega, 2003, Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis, Annals of the Rheumatic Diseases, 62, 74, 10.1136/ard.62.1.74 Herfarth, 2002, Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease, The American Journal of Gastroenterology, 97, 2688, 10.1111/j.1572-0241.2002.06064.x Hanauer, 2002, ACCENT I study group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial, Lancet, 359, 1541, 10.1016/S0140-6736(02)08512-4 Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, The New England Journal of Medicine, 353, 2462, 10.1056/NEJMoa050516 Jarnerot, 2005, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study, Gastroenterology, 128, 1805, 10.1053/j.gastro.2005.03.003 D'Haens, 2001, Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial, The American Journal of Gastroenterology, 96, 2564, 10.1111/j.1572-0241.2001.04705.x Sandborn, 2001, Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial, Gastroenterology, 121, 1088, 10.1053/gast.2001.28674 Baraliakos, 2005, Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data, Arthritis and Rheumatism, 53, 856, 10.1002/art.21588 Davis, 2003, Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial, Arthritis and Rheumatism, 48, 3230, 10.1002/art.11325 Oh, 2005, Development of Crohn's disease in a patient taking etanercept, The Journal of Rheumatology, 32, 752 Rudwaleit, 2005, Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept, Annals of the Rheumatic Diseases, 64, 1305, 10.1136/ard.2004.032441 Van den Brande, 2003, Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease, Gastroenterology, 124, 1774, 10.1016/S0016-5085(03)00382-2 Di Sabatino, 2004, Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease, Gut, 53, 70, 10.1136/gut.53.1.70 Sandborn, 2004, An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease, The American Journal of Gastroenterology, 99, 1984, 10.1111/j.1572-0241.2004.40462.x Papadakis, 2005, Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab, The American Journal of Gastroenterology, 100, 75, 10.1111/j.1572-0241.2005.40647.x